SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

191 hedge funds and large institutions have $446M invested in Sage Therapeutics in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 56 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
-7
Holders Change %
-3.54%
% of All Funds
2.56%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
37
Increased
59
Reduced
56
Closed
42
Calls
$7.52M
Puts
$4.19M
Net Calls
+$3.32M
Net Calls Change
+$3.85M

Top Buyers

1
MAP
Madison Avenue Partners
New York
$55.4M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
$13.8M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
$17.8M
4
AAM
Alpine Associates Management
Florida
$11.6M
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
$9.87M

Top Sellers

1
CP
Caligan Partners
New York
$0
2
TAL
TIG Advisors LLC
New York
$759K
3
Vanguard Group
Vanguard Group
Pennsylvania
$29.8M
4
DTC
Deep Track Capital
Connecticut
$0
5
BFM
Boothbay Fund Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CCM
226
Coldstream Capital Management
Washington
– -$14K -1,755 Closed
Northwestern Mutual Wealth Management
227
Northwestern Mutual Wealth Management
Wisconsin
– -$1.99K -250 Closed
SW
228
SVB Wealth
Massachusetts
– -$1.83K -230 Closed
SSG
229
Summit Securities Group
New York
– -$1.01K -127 Closed
Point72 Asset Management
230
Point72 Asset Management
Connecticut
– -$627 -79 Closed
CA
231
Continuum Advisory
Idaho
– -$398 -50 Closed
LFG
232
Larson Financial Group
Missouri
– -$398 -50 Closed
6 7 8 9
10